ChAd63-PfCAT

Developed for: malaria
Investigated by: Naval Medical Research Center · U.S. Army Medical Research and Development Command · United States Agency for International Development (USAID) · University of Oxford · Walter Reed Army Institute of Research (WRAIR)

today NCT03341754 · Ph 1

20192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03341754	Sep 2018 → Oct 2019	malaria	U.S. Army Medical Research and Development Command	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	ChAd63-PfCAT	“Priming Component (DNA) = NMRC-M3V-D-PfCAT (D-CAT) Boosting Component = ChAd63-PfCAT” NCT03341754 ↗